Update on the second-line treatment of <i>Helicobacter pylori</i> infection: a narrative review.

Publication Year: 2023

DOI:
10.1177/17562848231192750

PMCID:
PMC10478561

PMID:
37675247

Journal Information

Full Title: Therap Adv Gastroenterol

Abbreviation: Therap Adv Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by the Ministry of Science and Technology, Executive Yuan, Taiwan, ROC (Grant numbers: MOST 109-2314-B075B-007, MOST 110-2314-B-039-045 and MOST 111-2314-B-039-066), and the An Nan Hospital, China Medical University (Grant Numbers: ANHRF110-18, ANHRF ANHRF111-34 and ANHRF 111-44)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025